Catalent Shares Outstanding 2012-2020 | CTLT

Catalent shares outstanding history from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Catalent shares outstanding for the quarter ending September 30, 2020 were 0.167B, a 14.32% increase year-over-year.
  • Catalent 2020 shares outstanding were 0.165B, a 13.29% increase from 2019.
  • Catalent 2019 shares outstanding were 0.146B, a 9.61% increase from 2018.
  • Catalent 2018 shares outstanding were 0.133B, a 5.1% increase from 2017.
Catalent Annual Shares Outstanding
(Millions of Shares)
2020 165
2019 146
2018 133
2017 127
2016 126
2015 121
2014 76
2013 75
2012 75
2011 75
Catalent Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 167
2020-06-30 165
2020-03-31 153
2019-12-31 148
2019-09-30 146
2019-06-30 146
2019-03-31 147
2018-12-31 147
2018-09-30 142
2018-06-30 133
2018-03-31 135
2017-12-31 133
2017-09-30 128
2017-06-30 127
2017-03-31 127
2016-12-31 126
2016-09-30 126
2016-06-30 126
2016-03-31 126
2015-12-31 126
2015-09-30 126
2015-06-30 121
2015-03-31 126
2014-12-31 126
2014-09-30 106
2014-06-30 76
2014-03-31 76
2013-12-31 75
2013-09-30 76
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.899B $3.094B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.970B 41.96
Takeda Pharmaceutical (TAK) Japan $56.939B 10.62
Astellas Pharma (ALPMY) Japan $29.602B 18.49
Merck (MKGAF) Germany $22.933B 0.00
Eisai (ESALY) Japan $21.762B 18.96
UCB SA (UCBJF) Belgium $20.831B 0.00
Grifols, S.A (GRFS) Spain $13.235B 15.16
Neurocrine Biosciences (NBIX) United States $10.104B 79.52
Jazz Pharmaceuticals (JAZZ) Ireland $9.081B 14.67
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.772B 0.00
Ionis Pharmaceuticals (IONS) United States $8.340B 81.71
Arrowhead Pharmaceuticals (ARWR) United States $8.323B 0.00
United Therapeutics (UTHR) United States $7.204B 15.34
IPSEN SA ADR (IPSEY) France $7.040B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.853B 396.78
Sage Therapeutics (SAGE) United States $5.008B 0.00
PTC Therapeutics (PTCT) United States $4.547B 0.00
ChemoCentryx (CCXI) United States $4.271B 0.00
Hypermarcas (HYPMY) Brazil $4.117B 15.12
Cronos Group (CRON) Canada $3.807B 0.00
FibroGen (FGEN) United States $3.581B 0.00
Nektar Therapeutics (NKTR) United States $3.288B 0.00
Pacira BioSciences (PCRX) United States $3.193B 69.33
Corcept Therapeutics (CORT) United States $3.133B 30.30
Taro Pharmaceutical Industries (TARO) Israel $2.946B 15.04
Xencor (XNCR) United States $2.754B 0.00
Revolution Medicines (RVMD) United States $2.540B 0.00
Tilray (TLRY) Canada $2.006B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.804B 15.44
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.758B 0.00
Translate Bio (TBIO) United States $1.706B 0.00
Endo (ENDP) Ireland $1.663B 2.52
USANA Health Sciences (USNA) United States $1.660B 14.61
Heron Therapeutics (HRTX) United States $1.650B 0.00
Ocular Therapeutix (OCUL) United States $1.617B 0.00
Trillium Therapeutics (TRIL) Canada $1.465B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.439B 0.00
ImmunoGen (IMGN) United States $1.423B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.421B 9.88
Karyopharm Therapeutics (KPTI) United States $1.112B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.108B 0.00
Zogenix (ZGNX) United States $1.057B 0.00
Radius Health (RDUS) United States $1.029B 0.00
Indivior (INVVY) United States $1.029B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.937B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Acutus Medical (AFIB) United States $0.794B 0.00
ORGANOGENESIS (ORGO) United States $0.791B 0.00
Collegium Pharmaceutical (COLL) United States $0.755B 44.55
Esperion Therapeutics (ESPR) United States $0.750B 0.00
VAXART, INC (VXRT) United States $0.742B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.719B 0.00
Aerie Pharmaceuticals (AERI) United States $0.668B 0.00
Chinook Therapeutics (KDNY) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Ardelyx (ARDX) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.580B 0.00
Siga Technologies (SIGA) United States $0.564B 15.85
Harpoon Therapeutics (HARP) United States $0.540B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.536B 0.00
Molecular Templates (MTEM) United States $0.533B 0.00
PROFOUND MEDICL (PROF) Canada $0.472B 0.00
Sundial Growers (SNDL) Canada $0.465B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Altimmune (ALT) United States $0.453B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Summit Therapeutics (SMMT) United States $0.436B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
CASI Pharmaceuticals (CASI) United States $0.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.391B 0.00
Rafael Holdings (RFL) United States $0.381B 0.00
Concert Pharmaceuticals (CNCE) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.365B 9.51
Matinas Biopharma Holdings (MTNB) United States $0.321B 0.00
MEI Pharma (MEIP) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.315B 0.00
Nature's Sunshine Products (NATR) United States $0.299B 19.23
Jaguar Animal Health (JAGX) United States $0.297B 0.00
KalVista Pharmaceuticals (KALV) United States $0.294B 0.00
Jounce Therapeutics (JNCE) United States $0.292B 0.00
Redhill Biopharma (RDHL) Israel $0.282B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.280B 7.37
Menlo Therapeutics (VYNE) United States $0.274B 0.00
Otonomy (OTIC) United States $0.271B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
CTI BioPharma (CTIC) United States $0.249B 0.00
OptiNose (OPTN) United States $0.222B 0.00
IMV INC (IMV) Canada $0.221B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Oncternal Therapeutics (ONCT) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.194B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.178B 0.00
Infinity Pharmaceuticals (INFI) United States $0.171B 0.00
Taiwan Liposome (TLC) Taiwan $0.167B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.161B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.159B 0.00
IsoRay (ISR) United States $0.156B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Champions Oncology (CSBR) United States $0.148B 0.00
Heat Biologics (HTBX) United States $0.138B 0.00
Novan (NOVN) United States $0.137B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.135B 0.00
MediWound (MDWD) Israel $0.132B 0.00
Onconova Therapeutics (ONTX) United States $0.126B 0.00
Lipocine (LPCN) United States $0.101B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Nutriband (NTRB) United States $0.097B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.093B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.079B 153.00
ElectroCore (ECOR) United States $0.076B 0.00
Biomerica (BMRA) United States $0.074B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Recro Pharma (REPH) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
Iterum Therapeutics (ITRM) Ireland $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.77
Regulus Therapeutics (RGLS) United States $0.046B 0.00
PolarityTE (PTE) United States $0.045B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.58
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.030B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
KemPharm (KMPH) United States $0.027B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Flex Pharma (SLRX) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 33.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00